1)Araki S, et al. Incidence and In-Hospital Mortality of Neonatal Disseminated Intravascular Coagulation in Japan: An Observational Study of a Nationwide Hospital Claims Database. J UOEH. 2019; 41: 295-302.
2)Geyer-Roberts E, et al. Disseminated Intravascular Coagulation in Varying Age Groups Based on Clinical Conditions. Cureus. 2022; 14: e24362.
3)Go H, et al. Risk factors and treatments for disseminated intravascular coagulation in neonates. Ital J Pediatr. 2020; 46: 54.
4)Zimmermann P, Curtis N. COVID-19 in Children, Pregnancy and Neonates: A Review of Epidemiologic and Clinical Features. Pediatr Infect Dis J. 2020; 39: 469-477.
5)川口千晴,他.新生児DICの診断・治療に関する全国アンケート調査 新生児DIC全国調査.日産婦新生児血会誌.2016;26:43-53.
6)Egami N, et al. Clinical Impact of Heritable Thrombophilia on Neonatal-Onset Thromboembolism: A Nationwide Study in Japan. J Pediatr. 2021; 238: 259-267. e2.
7)Oren H, et al. Disseminated intravascular coagulation in pediatric patients: clinical and laboratory features and prognostic factors influencing the survival. Pediatr Hematol Oncol. 2005; 22: 679-688.
8)Kunwar S, et al. Diagnostic Scores and Treatment Options for Acute Disseminated Intravascular Coagulation in Children. Cureus 2021; 13: e17682.
9)Kongstad C, et al. Disseminated intravascular coagulation in children with cancer: A systematic review. Pediatr Hematol Oncol. 2020; 37: 390-411.
10)Ishimura M, et al. Fulminant sepsis/meningitis due to Haemophilus influenzae in a protein C-deficient heterozygote treated with activated protein C therapy. Eur J Pediatr. 2009; 168: 673-677.
11)白幡聡,他.新生児DIC診断・治療指針2016年度版.日産婦新生児血会誌.2016;25:3-34.
12)DIC診断基準作成委員会.日本血栓止血学会DIC診断基準 2017年版.日血栓止血会誌.2017;28:369-391.